Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
7.74M
-
Number of holders
-
17
-
Total shares
-
4.88M
-
Shares change
-
+4.63M
-
Total reported value, excl. options
-
$2.15M
-
Value change
-
+$2.04M
-
Number of buys
-
10
-
Number of sells
-
-3
-
Price
-
$0.44
Significant Holders of Kazia Therapeutics Limited - American Depositary Shares (KZIA) as of Q4 2023
16 filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q4 2023.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.88M shares
of 7.74M outstanding shares and own 63.07% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (2.48M shares), PLATINUM INVESTMENT MANAGEMENT LTD (1.82M shares), MORGAN STANLEY (202K shares), BANK OF MONTREAL /CAN/ (140K shares), HSBC HOLDINGS PLC (100K shares), TWO SIGMA SECURITIES, LLC (58.4K shares), XTX Topco Ltd (19.4K shares), ACADIAN ASSET MANAGEMENT LLC (18.7K shares), CITADEL ADVISORS LLC (12.8K shares), and BNP PARIBAS FINANCIAL MARKETS (12.7K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.